FDA upgrades recall on 160,000+ bottles of thyroid medication

The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as “subpotent” active ingredients.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup